Loading data for APUS — first visit, this takes a few seconds.
Apimeds Pharmaceuticals U... (APUS)
NYSE American: APUS
· Real-Time Price · USD
4.42
+0.42 (10.50%)
At close: Aug 19, 2026, 8:00 PM
4.19
-4.56%
After-hours: 7:51 PM
The price, the headline numbers and the latest news, in one place.
Apimeds Pharmaceuticals US Inc. (APUS) Stock Price, Analysis & Data
10.50% (1D)
No data available
| Bid | 4.35 |
| Market Cap | 6.63M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| n/a | |
| -35.98 | |
| n/a | |
| n/a | |
| P/B (ttm) | 6.76 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 4.46 |
| Volume | 17,775 |
| Avg. Volume (20D) | 52,707 |
| Open | 3.88 |
| Previous Close | 4.00 |
| Day's Range | 3.84 - 4.54 |
| 52-Week Range | 3.39 - 59.70 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About APUS
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc....
Sector Healthcare
IPO Date May 9, 2025
Employees n/a
Stock Exchange NYSE American
Ticker Symbol APUS
Website https://www.mindwavedao.com
Financial Performance
In 2025, Apimeds Pharmaceuticals US's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -6M, an increase of 331.74%.
Financial Statements